Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss 3 deals: Syngenta's deal with ChemChina, Starz potential for a future deal, and the Endurance / Constant Contact deal closing.

Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss free give aways in the everyday life and in the Dell, EMC Mega merger.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss all things square and flat from Apple to Iowa, as well as potential 20%+ annual returns from Hutchinson Technology.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss ways to detect deception and analysis IBM's Q4 earnings call.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss a better way to buy Time Warner and a company who blamed Justin Bieber for their poor performance.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss different ways to take advantage of the recent sell off and Mr. Market's elevated fear levels.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss Fondul's large discount to NAV, what's happening with Akorn, and closed end funds in general

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss Berkshire Hathaway as it approaches Warren Buffett's 1.2x share repurchase level.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss Constant Contact's merger, a potential acquisition of Del Frisco's, and David Bowie's Bowie Bonds.

Rangeley Capital’s Portfolio Managers, Andrew Walker and Chris DeMuth, discuss the merger of Baxalta and Shire, and how to increase your odds of winning the lottery.